Could melatonin be used in COVID‐19 patients with laryngopharyngeal reflux disease?
Open Access
- 10 June 2020
- journal article
- letter
- Published by Wiley in Journal of Medical Virology
- Vol. 93 (1), 92-93
- https://doi.org/10.1002/jmv.26150
Abstract
Click on the article title to read more.This publication has 6 references indexed in Scilit:
- The impact of laryngopharyngeal reflux disease on 95 hospitalized patients with COVID‐19 in Wuhan, China: A retrospective studyJournal of Medical Virology, 2020
- Melatonin supplementation and pro-inflammatory mediators: a systematic review and meta-analysis of clinical trialsEuropean Journal of Nutrition, 2019
- Effects of N-acetyl cysteine and melatonin on early reperfusion injury in patients undergoing coronary artery bypass graftingMedicine, 2018
- The potential therapeutic effect of melatonin in gastro-esophageal reflux diseaseBMC Gastroenterology, 2010
- Melatonin therapy to improve nocturnal sleep in critically ill patients: encouraging results from a small randomised controlled trialCritical Care, 2008
- Laryngopharyngeal reflux: Current concepts in pathophysiology, diagnosis, and treatmentInternational Journal of Speech-Language Pathology, 2008